Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Leukaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07686965
What this trial is testing

Lisaftoclax Plus Azacitidine Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients at High Risk of Relapse

Who this might be right for
Acute Myeloid Leukemia (AML)Maintenance TreatmentHematopoetic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 191
Testing effectiveness (Phase 2)Looking for participantsNCT06698003
What this trial is testing

Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Who this might be right for
T-Cell Leukemia/Lymphoma, AdultT-cell Leukemia/LymphomaT-cell Leukemia+1 more
Memorial Sloan Kettering Cancer Center 134
Early research (Phase 1)Study completedNCT03113695
What this trial is testing

Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome

Who this might be right for
Richter's SyndromeCLL
University of California, San Diego 4
Early research (Phase 1)Active Not RecruitingNCT03422393
What this trial is testing

Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Michael Choi 24
Testing effectiveness (Phase 2)WithdrawnNCT02053545
What this trial is testing

Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion

Who this might be right for
LeukemiaLymphomaMDS
Ann & Robert H Lurie Children's Hospital of Chicago
Not applicableNot Yet RecruitingNCT06643195
What this trial is testing

Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Re-treatment for Patients With High-Risk Acute Myeloid Leukemia

Who this might be right for
AML
Institute of Hematology & Blood Diseases Hospital, China 358
Not applicableWithdrawnNCT00900445
What this trial is testing

Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaUntreated Childhood Acute Lymphoblastic Leukemia
Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01181271
What this trial is testing

Tandem Auto-Allo Transplant for Lymphoma

Who this might be right for
Diffuse, Large B-Cell, LymphomaLymphoma, Low-GradeT-Cell Lymphoma+4 more
Massachusetts General Hospital 42
Testing effectiveness (Phase 2)Study completedNCT01422603
What this trial is testing

Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid LeukaemiaMyelodysplasia
University Hospital Southampton NHS Foundation Trust 9
Testing effectiveness (Phase 2)UnknownNCT03083054
What this trial is testing

Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
University of Campinas, Brazil 5
Testing effectiveness (Phase 2)Looking for participantsNCT04169737
What this trial is testing

Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT07779031
What this trial is testing

A Single-Arm, Open Phase I Clinical Study of Selinexor in Combination With Azacitidine for the Treatment of High-Risk AML/MDS Patients After Allo-HSCT

Who this might be right for
Acute Myeloid Leukaemia (AML)MDS (Myelodysplastic Syndrome)
Liping Dou 58
Testing effectiveness (Phase 2)Ended earlyNCT02229266
What this trial is testing

Randomised Controlled Phase-2 Trial to Determine the Efficacy of Adoptive Immunotherapy With NK Cells in High-risk AML

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 1
Large-scale testing (Phase 3)Looking for participantsNCT03793517
What this trial is testing

Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT

Who this might be right for
Stem Cell Transplant ComplicationsLeukemia, Myeloid, AcuteLeukemia Relapse
Peking University People's Hospital 55
Testing effectiveness (Phase 2)Study completedNCT00003658
What this trial is testing

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 60
Not applicableLooking for participantsNCT07613385
What this trial is testing

Individualized AML Treatment

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (AML)
City of Hope Medical Center 18
Large-scale testing (Phase 3)Study completedNCT00165178
What this trial is testing

Treatment of Acute Lymphoblastic Leukemia in Children

Who this might be right for
Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute 498
Early research (Phase 1)Study completedNCT00004904
What this trial is testing

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Northwestern University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03330821
What this trial is testing

Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Myelodysplasia-Related ChangesTherapy-Related Acute Myeloid Leukemia
University of Southern California 53
Early research (Phase 1)Study completedNCT00780104
What this trial is testing

Sirolimus in Combination With MEC in High Risk Myeloid Leukemias

Who this might be right for
Myeloid LeukemiasAMLLeukemia+1 more
Abramson Cancer Center at Penn Medicine 16
Next Page